Exact Mass: 738.338
Exact Mass Matches: 738.338
Found 106 metabolites which its exact mass value is equals to given mass value 738.338
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daclatasvir
5,5-(2,3,5,6,11,11b,2,3,5,6,11,11b-dodecahydro-11b,11b-propane-1,3-diyl-bis-oxazolo[3,2:1,2]pyrido[3,4-b]indol-2-yl)-bis-nicotinic acid dimethyl ester
cyclo(Pro-Gly-Gln-Pro-Pro-Tyr-Val)|cycloreticulin C
(17R)-4beta-acetoxy-8,14beta-epoxy-3beta-[beta-D-glucopyranosyl-(1->4)-alpha-L-cymaropyranosyloxy]-5alpha-card-20(22)-dihydroenolide|funingenoside L
(23S,24S)-spirost-5,25(27)-diene-1beta,3beta,23,24-tetrol 1-O-{O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranoside}|(23S,24S)-spirosta-5,25(27)-dien-1beta,3beta,23,24-tetrol 1-O-[alpha-L-rhamnopyranosyl-(1->2)]-alpha-L-arabinopyranoside|(23S,24S)-spirosta-5,25(27)-diene-1beta,3beta,23,24-tetrol 1-O-2)-alpha-L-arabinopyranoside>|(23S,24S)-spirosta-5,25(27)-diene-1beta,3beta,23,24-tetrol 1-O-alpha-L-rhamnopyranosyl-(1?2)-O-alpha-L-arabinopyranoside
8alpha-O-beta-D-glucopyranosyllabd-13E-15,19-diol 15,19,2,3,4,6-hexaacetate
Daclatasvir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(1R,2R,3R,4R,6R,8S,12S,13S,14R,15S)-4,6,12,13,15-pentaacetyloxy-3-hydroxy-4,8,11,11-tetramethyl-7,18-dioxo-19-oxatricyclo[13.4.0.02,6]nonadec-9-en-14-yl] 2-methylpropanoate
[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
{5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,4a,6-trimethyl-6-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-hexahydro-2h-naphthalen-1-yl}methyl acetate
14'-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-3,4,16'-triol
4,6,12,13,15-pentakis(acetyloxy)-3-hydroxy-4,8,11,11-tetramethyl-7,18-dioxo-19-oxatricyclo[13.4.0.0²,⁶]nonadec-9-en-14-yl 2-methylpropanoate
(1r,3r,4s,6s,8s,9s,10s,12r,13s,14r,15r)-1,8,10,12,14,15-hexakis(acetyloxy)-3,7,7,15-tetramethyl-11-methylidene-2-oxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-9-yl 2-methylpropanoate
(3as,3br,5ar,7s,9as,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(1r,4r,5r,7s,8r,9r,10r,11s,12s)-5-(acetyloxy)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-7-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl (2e)-2-methylbut-2-enoate
6-(3-{2-hydroxy-5-[3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)propyl]-4-methoxyphenyl}-1-(4-hydroxyphenyl)propyl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-7-ol
(2s)-6-[(1r)-3-{2-hydroxy-5-[(1r)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)propyl]-4-methoxyphenyl}-1-(4-hydroxyphenyl)propyl]-2-phenyl-3,4-dihydro-2h-1-benzopyran-7-ol
(2s,6s)-2-{[2,6-dihydroxy-4-methoxy-3-methyl-5-(3-methylbutanoyl)phenyl]methyl}-6-({2,6-dihydroxy-4-methoxy-3-methyl-5-[(2r)-2-methylbutanoyl]phenyl}methyl)-5-hydroxy-2,6-dimethyl-4-(3-methylbutanoyl)cyclohex-4-ene-1,3-dione
(1r,2r,3r,4r,6r,8s,9e,12s,13s,14r,15s)-3,6,12,13,15-pentakis(acetyloxy)-4-hydroxy-4,8,11,11-tetramethyl-7,18-dioxo-19-oxatricyclo[13.4.0.0²,⁶]nonadec-9-en-14-yl 2-methylpropanoate
[(1r,3as,3bs,5s,5as,7s,9as,11ar)-5-{[(2s,3s,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-(sulfooxy)oxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methyl-4-oxoheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
3-acetyl-1-cinnamoyl-11-methoxymeliacarpinin
{"Ingredient_id": "HBIN007865","Ingredient_name": "3-acetyl-1-cinnamoyl-11-methoxymeliacarpinin","Alias": "NA","Ingredient_formula": "C39H46O14","Ingredient_Smile": "NA","Ingredient_weight": "738.784","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8190","PubChem_id": "NA","DrugBank_id": "NA"}